Antibody shows promise in Crohn's diseaseBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7081.623m (Published 01 March 1997) Cite this as: BMJ 1997;314:623
- Jacqui Wise
A genetically engineered antibody may be a promising new treatment for Crohn's disease, according to a small randomised controlled trial.
Previous studies have suggested raised concentrations of tumour necrosis factor alpha, which stimulates the immune system, are associated …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial